Chikungunya virus spreads to new vectors

Researchers at the University of Texas Medical Branch have discovered how a key protein switch allows Chikungunya Virus (CHIKV) to spread to new vectors.

The study, published December 7 in PLoS Pathogens, explains how the virus has increased its ability to infect and be transmitted by the Asian tiger mosquito, Aedes albopictus.

CHIKV is an emerging arbovirus associated with several recent large-scale epidemics of arthritic disease. The virus has formerly been known to be carried primarily by the mosquito Aedes aegypti. However, a recent epidemic in the Indian Ocean islands suggested that something else was carrying the virus, as Ae. aegypti are not found there. In fact the relative Asian tiger mosquito, Ae. albopictus, was present. This prompted the team, led by Dr. Stephen Higgs, to look further into the virus.

In an earlier study it had been found that the epidemics on islands in the Indian Ocean were associated with a strain of CHIKV with a mutation in the envelope protein gene (E1-A226V). Therefore, the researchers investigated the role of the E1-A226V mutation on the fitness of CHIKV in both types of mosquitoes. The team infected mosquitoes with two genetically-engineered clones of the virus, one with the mutation and the other without.

The team found the mutant virus out-competed the other virus with respect to transmission by the tiger mosquito. This proved that EI-A226V is directly responsible for CHIKV adaptation to the Asian tiger mosquito, explaining why the virus was found in an area which lacks the typical vector mosquito.

The Asian tiger mosquito is present in many countries. Both mosquito species are currently present in the U.S. and the Asian tiger mosquito is spreading in Europe. The findings suggest that, especially with the global climate warming, CHIKV could expand to new geographic locations.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
SARS-CoV-2 hijacks cholesterol trafficking to fuel infection and evade immune responses